PRIVATE LABEL SINGLE-BOTTLE SOLUTION
KINODIN supports private label 5% minoxidil topical solution projects using a single 60ml dropper bottle for men-focused brands, distributors and qualified pharmaceutical partners. The product is developed as one retail SKU rather than a three- or six-bottle kit. Formula, minoxidil concentration basis, bottle, pipette, bulb, closure, label, carton, testing and destination-market documentation are reviewed together. Sampling can coordinate formula performance, dropper function and the intended individual retail presentation. Intended users, directions, warnings, claims and market authorization must be established for the specific finished product before commercial distribution.
A 60ml single bottle serves a different commercial purpose from multi-bottle kits. It can support initial product launches, independent retail listings, pharmacy or distributor evaluation, sample-to-order conversion and brands that prefer customers to purchase one unit at a time.
The page focuses on the individual product’s formula, dropper delivery and retail carton. Three-bottle and six-bottle pages remain separate because they add multi-unit assembly, inserts, component counting and kit-level traceability.
| Item | Project direction | Required confirmation |
|---|---|---|
| Dosage form | Minoxidil topical solution | Complete formula, solvent system and market pathway |
| Active | 5% minoxidil direction | Concentration basis, raw-material identity, assay and impurities |
| Nominal fill | 60ml / 2 fl oz concept | Actual fill, tolerance and required market declaration |
| Primary container | Glass or compatible plastic bottle | Barrier, light protection, solvent resistance and neck finish |
| Dispenser | Dropper with pipette and bulb | Material, graduation, uptake, output, leakage and compatibility |
| Retail packaging | Bottle label plus optional individual carton | Artwork, required text, insert and tamper-evident features |
| Intended users | Men-focused direction | Destination-market authorization, age range, directions and warnings |
A 5% active declaration is only one part of the specification. The full solvent and inactive-ingredient system must keep minoxidil dissolved, support the intended application and remain compatible with the bottle and dropper throughout shelf life.
The dropper is a functional delivery component, not only a visual packaging choice. Bottle neck, wiper, pipette length, bulb material, closure torque and graduation marks should be selected together.
Testing should assess liquid uptake, release, output variation, dripping, leakage, bulb recovery, formula contact, residue around the bottle neck and performance from the first use to the final portion of the bottle.
A graduated pipette can support dose communication only when the graduation accuracy and finished-product directions are established. The number of uses per bottle depends on the approved application quantity and frequency.
This B2B page does not publish one global consumer dose, application frequency or result timeline. Those statements must come from the applicable market authorization and final label.
Brands may develop a standalone labeled bottle or add an individual retail carton. Bottle color, cap finish, dropper components, label material, print method and carton structure depend on formula compatibility, brand positioning, required information and MOQ.
Artwork must leave enough space for the active declaration, net contents, directions, warnings, batch traceability and market-specific information. Original brand identity should be used throughout the bottle, carton and sales images.
The product must use the customer’s own brand, artwork and packaging identity. Third-party brand names, similar spellings, copied graphics, comparison statements and confusingly similar trade dress should not appear on the page, label or product images.
Ingredient information does not automatically validate a customized finished product. Claims must match the specific formulation, evidence, authorization pathway and destination-market rules.
MOQ depends on the formula route, bottle, dropper, label, individual carton, testing and documentation. A single-bottle SKU does not mean an order MOQ of one bottle; quotations should state the number of finished retail units.
Available project files may include formula information, raw-material documents, safety data, batch COA, test reports, packaging specifications and stability information. Scope is confirmed according to the actual manufacturing party, formula, package, batch and destination country.
Yes. The proposed retail SKU contains one 60ml topical-solution bottle with one compatible dropper and optional individual carton.
This page covers one standalone retail unit. The six-bottle page includes secondary-kit structure, component counting and multi-unit assembly.
No. The intended dosage form is a 5% minoxidil topical solution and should not be categorized or marketed as ordinary hair oil.
A graduated pipette can be evaluated, but mark accuracy and its relationship to the final directions must be verified.
Yes. Bottle color, dropper components, label, carton and print finish are reviewed according to compatibility, information needs and MOQ.
No. A duration statement depends on the applicable directions, quantity per application and frequency for the specific finished product.
Potential factors include solvent balance, temperature, evaporation, formula changes and package performance. These require structured investigation and stability testing.
MOQ depends on the formula, bottle, dropper, label, carton, testing, documentation and destination-market requirements.
Provide the destination country, regulatory pathway, target order quantity, bottle and dropper preference, packaging artwork needs and requested documents.
Send KINODIN your destination country, product pathway, order quantity, bottle preference, dropper requirements and packaging reference for a project-specific review.
Minoxidil Topical ProductsMinoxidil Topical SolutionRequest a Project Review
Minoxidil-containing products may be regulated as medicinal or drug products in the destination market. Product availability, formulation, packaging, labeling, claims and supporting documents are evaluated according to the intended country and project requirements. KINODIN does not represent that a customized finished product is approved or registered in a specific market unless confirmed by the applicable authorization documents.
contact us
contact us for free sample !
Copyright © 2026 Foshan Younik Cosmetics Co., Limited. All Rights Reserved.